fbpx
Medical Innovation Exchange

Biogen-Eisai go for another biomarker approval in Alzheimer's with lecanemab—and snag priority review

https://www.fiercebiotech.com/biotech/biogen-eisais-alzheimers-follow-granted-priority-review-setting-acclerated-review-decision

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.